4//SEC Filing
Scott John K Jr. 4
Accession 0001415889-23-015898
CIK 0000810509other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 6:26 PM ET
Size
14.6 KB
Accession
0001415889-23-015898
Insider Transaction Report
Form 4
Scott John K Jr.
10% Owner
Transactions
- Other
Series G Redeemable Preferred Stock
2023-11-27−2,270→ 0 total - Other
Series I Convertible Preferred Stock
2023-11-27$1000.00/sh−2,400$2,400,000→ 0 totalExercise: $0.16→ Common Stock (15,000,000 underlying) - Other
Series J Convertible Preffered Stock
2023-11-27$100.00/sh+64,289$6,428,900→ 64,289 totalExercise: $0.10→ Common Stock (61,816,346 underlying)
Footnotes (2)
- [F1]Navidea entered into a Loan and Exchange Agreement with the Reporting Person, pursuant to which he surrendered 2,270 shares of Series G Preferred Stock, par value $.001 per share plus accrued and unpaid dividends thereon, and 2,400 shares of Series I Preferred Stock, par value $.001 per share, and other consideration, in exchange for 64,289 shares of Series J Preferred Stock, par value $.001.
- [F2]Series J Convertible Preferred Stock, par value $.001 per share, is convertible at any time and has no expiration date.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeother
Related Parties
1- filerCIK 0001753763
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 6:26 PM ET
- Size
- 14.6 KB